Never miss a Delaware County story!
Undisclosed investors are purchasing 7.8 million shares of NRx Pharmaceutical stock, raising $25 million to finance the Radnor company’s development of therapy and…
NRx Pharmaceuticals has now added a patent application to its paperwork for the COVID-19 therapy drug Zyesami, writes John George for Philadelphia Business Journal…
NRx Pharmaceuticals out of Radnor has once again filed an application with the Food and Drug Administration for emergency use of its experimental COVID-19…
Patients treated with an NRx Pharmaceuitcals drug candidate targeting COVID-19 showed “substantial improvement,” an analysis shows.
The news caused the Radnor company’s stock…
A Radnor pharmaceutical company , NRx, active in COVID-19 research is entering into a multi-million dollar private stock sale, writes John George for Philadelphia…
With COVID-19 cases growing by 1,000 cases a day, the country of Georgia has issued an emergency authorization to use a COVID-19…
Before we send you to this site, please subscribe to our daily newsletter.